Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'. The following are the other relevant details related to the trial:
Therapeutic Area: Neurology
Trial Centre(s):
KK Women's & Children's Hospital
Trial Status: NA
Principal Investigator(s):
Dr Yap Zhi Min
Published by HT Digital Content Services with permission from Health Daily Digest....